Mahadev Mukherjee

Head of AI Transformation at Bajoria Group. Founder of GARBHAYAN AI — edge-deployed IVF monitoring system. 18 years in pharma with 12 years in gynecology and IVF. Pharma AI Consultant specializing in Health AI, regulatory compliance, and enterprise AI deployment. Based in Kolkata, India.

The Silent Profit Killer: Why Indian Enterprises Must Switch to Agentic AI by 2026

Leave a Comment / Industrial AI Strategy /

The Hidden Cost of Human Response LagIn high-ticket B2B environments across Indian Real Estate, Pharmaceuticals, and enterprise sales, demand is not the constraint—time is. The moment a prospect submits a Meta lead, a narrow window of intent opens. This window is measured not in hours, but in minutes. Yet most enterprises still rely on human-driven […]

The Silent Profit Killer: Why Indian Enterprises Must Switch to Agentic AI by 2026 Read More »

AI-Driven Doctor Profiling in Pharma: Turning Generic Promotion into Precision Clinical Dialogue

Leave a Comment / Uncategorized /

AI Precision Communication in P… Pharmaceutical communication is entering an “attention economy” where access is not earned by frequency, but by relevance. The legacy commercial model—built on share of voice and prescription-volume segmentation—assumed that more touchpoints would translate into more impact. That assumption is now structurally unstable, because modern clinicians filter out low-utility signals and

AI-Driven Doctor Profiling in Pharma: Turning Generic Promotion into Precision Clinical Dialogue Read More »

Blue-wheel framework for AI-enabled pharmaceutical management showing a continuous decision loop from insight generation to strategic recalibration with the customer at the center.

AI-Enabled Management in Pharma: A Continuous Cycle of Strategic Insight and Leadership

Leave a Comment / Uncategorized /

1. Introduction: Problem Framing and Relevance Artificial intelligence is improving decision-making in many industries, especially where leaders can learn quickly from data and adjust course. Pharmaceutical management has been slower to bring AI into the places where strategy is made: leadership meetings, brand steering, resource allocation, and long-term planning. This is often described as a

AI-Enabled Management in Pharma: A Continuous Cycle of Strategic Insight and Leadership Read More »

Subscribe
Subscribe